Tech Company Financing Transactions

Perosphere Funding Round

On 10/26/2015, Perosphere raised $2.1 million in Series B investment from private investors.

Transaction Overview

Company Name
Announced On
10/26/2015
Transaction Type
Venture Equity
Amount
$2,123,255
Round
Series B
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing. Amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt.

Company Information

Company Status
Private & Independent
Industry
Biopharmaceutical
Mailing Address
20 Kenosia Ave.
Danbury, CT 06810
USA
Email Address
Overview
Perosphere is a specialty pharmaceutical company with internationally recognized drug delivery expertise. Perosphere identifies market opportunities where application of drug delivery technology to a drug already on the market can create a new medical use for that drug or enhance its safety, efficacy or ease of use.
Profile
Perosphere LinkedIn Company Profile
Social Media
Perosphere Company Twitter Account
Company News
Perosphere News
Facebook
Perosphere on Facebook
YouTube
Perosphere on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Solomon Steiner
  Solomon Steiner LinkedIn Profile  Solomon Steiner Twitter Account  Solomon Steiner News  Solomon Steiner on Facebook
Chief Medical Officer
James Costin
  James Costin LinkedIn Profile  James Costin Twitter Account  James Costin News  James Costin on Facebook
Chief Technical Officer
Sasha Bakhru
  Sasha Bakhru LinkedIn Profile  Sasha Bakhru Twitter Account  Sasha Bakhru News  Sasha Bakhru on Facebook
VP - Bus. Development
Peter van Straelen
  Peter van Straelen LinkedIn Profile  Peter van Straelen Twitter Account  Peter van Straelen News  Peter van Straelen on Facebook
VP - Finance
Philip Sussman
  Philip Sussman LinkedIn Profile  Philip Sussman Twitter Account  Philip Sussman News  Philip Sussman on Facebook
VP - R & D
Bryan Laulicht
  Bryan Laulicht LinkedIn Profile  Bryan Laulicht Twitter Account  Bryan Laulicht News  Bryan Laulicht on Facebook
VP - Regulatory Affairs
Robert Hauser
  Robert Hauser LinkedIn Profile  Robert Hauser Twitter Account  Robert Hauser News  Robert Hauser on Facebook


 

 

Browse more venture capital transactions:

Prev: 10/26/2015: WiserCare venture capital transaction
Next: 10/26/2015: Petnet venture capital transaction

 

Share this article

 


About Our VC Transactions Data

We do our best to report on every notable VC transaction. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary